Spyre Therapeutics Ownership 2024 | Who Owns Spyre Therapeutics Now?

Overview ForecastFinancials Chart

Institutional Ownership

17.16%

Insider Ownership

2.40%

Retail Ownership

80.43%

Institutional Holders

1.00

Spyre Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
YU FAN	-	-	-	-737,000	-100.00%	-	Jun 30, 2024

Spyre Therapeutics's largest institutional shareholder is YU FAN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
YU FAN	-	-	-	-737,000	-100.00%	-	Jun 30, 2024

The largest Spyre Therapeutics shareholder by % of total assets is YU FAN. The company owns 0.00 shares of Spyre Therapeutics (AGLE), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
YU FAN	-	-	-	-737,000	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Spyre Therapeutics's largest institutional buyer is YU FAN. The company purchased -0.74M stocks of AGLE, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
YU FAN	-	-	-	-737,000	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Spyre Therapeutics's biggest institutional seller is YU FAN. The company sold -0.74M shares of AGLE, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
YU FAN	-	-	-	-737,000	-100.00%	-	Jun 30, 2024

Spyre Therapeutics's largest sold out institutional shareholder by shares sold is YU FAN, sold -0.74M shares, valued at -, as of undefined.

Spyre Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD VALLEY FORGE FUNDS	0.06%	33,281	-	-	Mar 31, 2024
BRIDGEWAY FUNDS INC	0.06%	150,000	-	-	Mar 28, 2024
FIDELITY ADVISOR SERIES VII	0.04%	353,495	353,495	-	Jan 31, 2024
FORUM FUNDS II	0.03%	28,600	-	-	Jan 31, 2024
Vericimetry Funds	0.03%	2,360	-	-	Mar 31, 2024
FRANKLIN STRATEGIC SERIES	0.03%	220,000	220,000	-	Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC	0.01%	71,346	-	-	Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.01%	5,803	-	-	Mar 31, 2024
FIDELITY SECURITIES FUND	0.01%	671,695	671,695	-	Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 1	0.01%	1,277	-	-	Mar 31, 2024
FIDELITY CAPITAL TRUST	0.01%	62,004	62,004	-	Jan 31, 2024
ALPS ETF Trust	0.00%	47,792	-	-	Feb 29, 2024
DRIEHAUS MUTUAL FUNDS	0.00%	33,863	-	-	Mar 28, 2024
FIDELITY CONCORD STREET TRUST	0.00%	552,929	-	-	Feb 29, 2024
North Square Investments Trust	0.00%	24,985	-	-	Jan 31, 2024
SCHWAB CAPITAL TRUST	0.00%	106,810	-	-	Feb 29, 2024
VANGUARD QUANTITATIVE FUNDS	0.00%	11,700	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	632,341	-	-	Mar 31, 2024
Calvert Variable Products, Inc.	0.00%	3,710	-	-	Mar 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST	0.00%	5,237	-	-	Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	34,242	-	-	Mar 31, 2024
Brinker Capital Destinations Trust	0.00%	48,359	-	-	Feb 29, 2024
SunAmerica Specialty Series	0.00%	346	-	-	Apr 30, 2021
TIAA-CREF LIFE FUNDS	0.00%	1,425	-	-	Mar 31, 2024
PRUDENTIAL INVESTMENT PORTFOLIOS, INC.	0.00%	4,715	-	-	Mar 28, 2024
Voya VARIABLE PORTFOLIOS INC	0.00%	15,466	-	-	Mar 31, 2024
AdvisorShares Trust	0.00%	1,157	-	-	Mar 28, 2024
Global X Funds	0.00%	11,563	-	-	Jan 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC	0.00%	1,275	-	-	Mar 31, 2024
GPS Funds I	0.00%	1,397	-	-	Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	243,231	-	-	Jan 31, 2024
ALLSPRING MASTER TRUST	0.00%	12,074	-	-	Feb 29, 2024
RBB FUND, INC.	0.00%	15,646	-	-	Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST	0.00%	10,100	-	-	Mar 31, 2024
PACE SELECT ADVISORS TRUST	0.00%	49,384	-	-	Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST	0.00%	20,202	-	-	Mar 31, 2024
Blackstone Alternative Investment Funds	0.00%	8,900	-1,700	-16.04%	Mar 31, 2023
NORTHERN FUNDS	0.00%	19,998	-	-	Mar 28, 2024
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	1,556	-	-	Mar 31, 2024
RYDEX SERIES FUNDS	0.00%	386	-	-	Dec 31, 2023
ProFunds	0.00%	867	-	-	Mar 31, 2024
Dimensional ETF Trust	0.00%	32,664	-	-	Jan 31, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST	0.00%	3,984	-	-	Dec 31, 2023
FIDELITY SALEM STREET TRUST	0.00%	290,838	-	-	Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS	0.00%	138,178	-	-	Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND	0.00%	66,026	-	-	Mar 31, 2024
T. Rowe Price Index Trust, Inc.	0.00%	1,378	-	-	Feb 29, 2024
RYDEX DYNAMIC FUNDS	0.00%	213	-	-	Dec 31, 2023
VALIC Co I	0.00%	14,979	-	-	Feb 29, 2024
PENN SERIES FUNDS INC	0.00%	1,500	-	-	Mar 28, 2024
PGIM ETF TRUST	0.00%	2,909	-	-	Feb 29, 2024
Guggenheim Active Allocation Fund	0.00%	240	-	-	Feb 29, 2024
RYDEX VARIABLE TRUST	0.00%	39	-	-	Dec 31, 2023
NATIONWIDE MUTUAL FUNDS	0.00%	4,308	-	-	Jan 31, 2024
TIAA-CREF FUNDS	0.00%	100,392	-	-	Mar 31, 2024
Columbia Funds Variable Series Trust II	0.00%	1,000	-	-	Mar 31, 2024
SEI INSTITUTIONAL MANAGED TRUST	0.00%	78,313	-	-	Dec 31, 2023
MUTUAL FUND SERIES TRUST	0.00%	110,000	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	5,693	-	-	Jan 31, 2024
RUSSELL INVESTMENT CO	0.00%	7,258	-	-	Jan 31, 2024
PROSHARES TRUST	0.00%	5,145	-	-	Feb 29, 2024
HC CAPITAL TRUST	0.00%	652	-	-	Mar 31, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	2,578	2,578	-	Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS	0.00%	1,772	-	-	Feb 29, 2024
Brighthouse Funds Trust II	0.00%	15,353	-	-	Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	0.00%	36,100	-	-	Mar 31, 2024
RUSSELL INVESTMENT FUNDS	0.00%	1,531	-	-	Mar 31, 2024
ETF Series Solutions	0.00%	278	-	-	Jan 31, 2024
iShares U.S. ETF Trust	0.00%	1,431	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	3,762	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	8,492	-	-	Mar 31, 2024
PACIFIC SELECT FUND	0.00%	20,364	-	-	Mar 31, 2024
Legg Mason Global Asset Management Trust	0.00%	30,064	-	-	Jan 31, 2024
Invesco Exchange-Traded Fund Trust II	0.00%	1,135	-	-	Jan 31, 2024
SUNAMERICA SERIES TRUST	0.00%	1,300	-	-	Mar 31, 2024
SUNAMERICA SERIES TRUST	0.00%	1,300	-	-	Jan 31, 2024
MASSMUTUAL SELECT FUNDS	0.00%	3,519	-	-	Dec 31, 2023
Bridge Builder Trust	0.00%	14,836	-	-	Mar 31, 2024
AMERICAN CENTURY ETF TRUST	0.00%	340	-	-	Feb 29, 2024
iSHARES TRUST	0.00%	33,740	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	390	-	-	Jan 31, 2024
Meeder Funds	0.00%	8	-	-	Mar 31, 2024
BlackRock Variable Series Funds, Inc.	0.00%	5,227	-	-	Mar 31, 2024
BLACKROCK FUNDS	0.00%	4,956	-	-	Mar 28, 2024
Advisors' Inner Circle Fund III	0.00%	53	-	-	Jan 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST	0.00%	9,300	-	-	Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	903	-	-	Mar 31, 2024
PRINCIPAL FUNDS, INC.	0.00%	2,570	-	-	Feb 29, 2024
John Hancock Funds II	0.00%	5,184	-	-	Feb 29, 2024
Legg Mason Global Asset Management Trust	0.00%	1,202	-	-	Jan 31, 2024

Spyre Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 33.28K shares, compromising 0.06% of its total assets.

Spyre Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 24	1	-
30 Sep, 23	3	-92.86%
30 Jun, 23	42	-
31 Mar, 23	42	-16.00%
31 Dec, 22	50	-1.96%
30 Sep, 22	51	-16.39%
30 Jun, 22	61	-22.78%
31 Mar, 22	79	-8.14%
31 Dec, 21	86	11.69%
30 Sep, 21	77	-2.53%
30 Jun, 21	79	-8.14%
31 Mar, 21	86	-5.49%
31 Dec, 20	91	-2.15%
30 Sep, 20	93	6.90%
30 Jun, 20	87	27.94%
31 Mar, 20	68	-1.45%
31 Dec, 19	69	-1.43%
30 Sep, 19	70	-7.89%
30 Jun, 19	76	8.57%
31 Mar, 19	70	16.67%
31 Dec, 18	60	1.69%
30 Sep, 18	59	-7.81%
30 Jun, 18	64	68.42%
31 Mar, 18	38	22.58%
31 Dec, 17	31	-
30 Sep, 17	31	-
30 Jun, 17	31	34.78%
31 Mar, 17	23	-8.00%
31 Dec, 16	25	-10.71%
30 Sep, 16	28	16.67%
30 Jun, 16	24	-

As of 31 Mar 24, 1 institutions are holding Spyre Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 24	737,000	-
30 Sep, 23	318,486	-99.55%
30 Jun, 23	70,894,681	71.57%
31 Mar, 23	41,322,333	-3.15%
31 Dec, 22	42,665,939	-4.53%
30 Sep, 22	44,689,986	-9.53%
30 Jun, 22	49,400,101	19.23%
31 Mar, 22	41,430,905	3.86%
31 Dec, 21	39,889,951	-1.69%
30 Sep, 21	40,576,293	-1.20%
30 Jun, 21	41,067,942	-1.26%
31 Mar, 21	41,593,818	0.34%
31 Dec, 20	41,453,210	6.78%
30 Sep, 20	38,821,585	2.14%
30 Jun, 20	38,007,670	84.59%
31 Mar, 20	20,590,595	-0.33%
31 Dec, 19	20,658,980	2.93%
30 Sep, 19	20,071,384	0.27%
30 Jun, 19	20,017,268	2.77%
31 Mar, 19	19,477,890	18.80%
31 Dec, 18	16,396,178	11.90%
30 Sep, 18	14,652,115	-0.25%
30 Jun, 18	14,688,579	73.30%
31 Mar, 18	8,476,047	6.96%
31 Dec, 17	7,924,820	1.57%
30 Sep, 17	7,802,680	-1.39%
30 Jun, 17	7,912,372	53.08%
31 Mar, 17	5,168,676	-7.75%
31 Dec, 16	5,602,738	-5.50%
30 Sep, 16	5,928,539	7.23%
30 Jun, 16	5,528,832	-

Spyre Therapeutics (AGLE) has 737.00K shares outstanding as of 31 Mar 24, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 24	17.16%	-
30 Sep, 23	7.42%	0.00%
30 Jun, 23	1854.62%	0.15%
31 Mar, 23	1095.94%	0.07%
31 Dec, 22	1265.59%	0.09%
30 Sep, 22	1186.07%	0.05%
30 Jun, 22	1502.27%	0.06%
31 Mar, 22	1569.44%	0.07%
31 Dec, 21	1516.85%	0.06%
30 Sep, 21	1541.90%	0.06%
30 Jun, 21	1564.33%	0.06%
31 Mar, 21	1585.03%	0.06%
31 Dec, 20	1579.67%	0.06%
30 Sep, 20	1559.34%	0.05%
30 Jun, 20	1794.79%	0.07%
31 Mar, 20	1555.29%	0.06%
31 Dec, 19	1560.45%	0.07%
30 Sep, 19	1525.45%	0.07%
30 Jun, 19	1523.83%	0.05%
31 Mar, 19	1678.45%	0.04%
31 Dec, 18	1968.56%	0.07%
30 Sep, 18	1666.00%	0.05%
30 Jun, 18	1782.71%	0.11%
31 Mar, 18	1270.99%	0.07%
31 Dec, 17	1309.61%	0.09%
30 Sep, 17	1188.72%	0.06%
30 Jun, 17	1401.50%	0.15%
31 Mar, 17	966.77%	0.05%
31 Dec, 16	1430.48%	0.12%
30 Sep, 16	1112.21%	0.08%
30 Jun, 16	1173.74%	-

As of 31 Mar 24, Spyre Therapeutics is held by 17.16% institutional shareholders, representing a 0.00% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 24	1	-
30 Sep, 23	-	-100.00%
30 Jun, 23	20	66.67%
31 Mar, 23	12	-42.86%
31 Dec, 22	21	50.00%
30 Sep, 22	14	-54.84%
30 Jun, 22	31	-13.89%
31 Mar, 22	36	-20.00%
31 Dec, 21	45	36.36%
30 Sep, 21	33	3.13%
30 Jun, 21	32	18.52%
31 Mar, 21	27	-37.21%
31 Dec, 20	43	4.88%
30 Sep, 20	41	-39.71%
30 Jun, 20	68	119.35%
31 Mar, 20	31	3.33%
31 Dec, 19	30	-
30 Sep, 19	30	-40.00%
30 Jun, 19	50	21.95%
31 Mar, 19	41	46.43%
31 Dec, 18	28	-9.68%
30 Sep, 18	31	-42.59%
30 Jun, 18	54	100.00%
31 Mar, 18	27	80.00%
31 Dec, 17	15	36.36%
30 Sep, 17	11	-31.25%
30 Jun, 17	16	33.33%
31 Mar, 17	12	20.00%
31 Dec, 16	10	-23.08%
30 Sep, 16	13	-45.83%
30 Jun, 16	24	-

1 institutional shareholders have increased their position in AGLE stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 24	-	-
30 Sep, 23	2	-75.00%
30 Jun, 23	8	-11.11%
31 Mar, 23	9	12.50%
31 Dec, 22	8	-38.46%
30 Sep, 22	13	-13.33%
30 Jun, 22	15	-42.31%
31 Mar, 22	26	18.18%
31 Dec, 21	22	-8.33%
30 Sep, 21	24	-11.11%
30 Jun, 21	27	-20.59%
31 Mar, 21	34	25.93%
31 Dec, 20	27	-10.00%
30 Sep, 20	30	130.77%
30 Jun, 20	13	-40.91%
31 Mar, 20	22	29.41%
31 Dec, 19	17	-22.73%
30 Sep, 19	22	144.44%
30 Jun, 19	9	-25.00%
31 Mar, 19	12	-25.00%
31 Dec, 18	16	-5.88%
30 Sep, 18	17	325.00%
30 Jun, 18	4	-
31 Mar, 18	-	-100.00%
31 Dec, 17	3	-57.14%
30 Sep, 17	7	-12.50%
30 Jun, 17	8	60.00%
31 Mar, 17	5	25.00%
31 Dec, 16	4	-42.86%
30 Sep, 16	7	-
30 Jun, 16	-	-

- institutional shareholders have reduced their position in AGLE stock as of 31 Mar 24 compared to 2 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 24	1	-	737,000	-	17.16%	-	1	-	-	-
30 Sep, 23	3	-92.86%	318,486	-99.55%	7.42%	0.00%	-	-100.00%	2	-75.00%
30 Jun, 23	42	-	70,894,681	71.57%	1854.62%	0.15%	20	66.67%	8	-11.11%
31 Mar, 23	42	-16.00%	41,322,333	-3.15%	1095.94%	0.07%	12	-42.86%	9	12.50%
31 Dec, 22	50	-1.96%	42,665,939	-4.53%	1265.59%	0.09%	21	50.00%	8	-38.46%
30 Sep, 22	51	-16.39%	44,689,986	-9.53%	1186.07%	0.05%	14	-54.84%	13	-13.33%
30 Jun, 22	61	-22.78%	49,400,101	19.23%	1502.27%	0.06%	31	-13.89%	15	-42.31%
31 Mar, 22	79	-8.14%	41,430,905	3.86%	1569.44%	0.07%	36	-20.00%	26	18.18%
31 Dec, 21	86	11.69%	39,889,951	-1.69%	1516.85%	0.06%	45	36.36%	22	-8.33%
30 Sep, 21	77	-2.53%	40,576,293	-1.20%	1541.90%	0.06%	33	3.13%	24	-11.11%
30 Jun, 21	79	-8.14%	41,067,942	-1.26%	1564.33%	0.06%	32	18.52%	27	-20.59%
31 Mar, 21	86	-5.49%	41,593,818	0.34%	1585.03%	0.06%	27	-37.21%	34	25.93%
31 Dec, 20	91	-2.15%	41,453,210	6.78%	1579.67%	0.06%	43	4.88%	27	-10.00%
30 Sep, 20	93	6.90%	38,821,585	2.14%	1559.34%	0.05%	41	-39.71%	30	130.77%
30 Jun, 20	87	27.94%	38,007,670	84.59%	1794.79%	0.07%	68	119.35%	13	-40.91%
31 Mar, 20	68	-1.45%	20,590,595	-0.33%	1555.29%	0.06%	31	3.33%	22	29.41%
31 Dec, 19	69	-1.43%	20,658,980	2.93%	1560.45%	0.07%	30	-	17	-22.73%
30 Sep, 19	70	-7.89%	20,071,384	0.27%	1525.45%	0.07%	30	-40.00%	22	144.44%
30 Jun, 19	76	8.57%	20,017,268	2.77%	1523.83%	0.05%	50	21.95%	9	-25.00%
31 Mar, 19	70	16.67%	19,477,890	18.80%	1678.45%	0.04%	41	46.43%	12	-25.00%
31 Dec, 18	60	1.69%	16,396,178	11.90%	1968.56%	0.07%	28	-9.68%	16	-5.88%
30 Sep, 18	59	-7.81%	14,652,115	-0.25%	1666.00%	0.05%	31	-42.59%	17	325.00%
30 Jun, 18	64	68.42%	14,688,579	73.30%	1782.71%	0.11%	54	100.00%	4	-
31 Mar, 18	38	22.58%	8,476,047	6.96%	1270.99%	0.07%	27	80.00%	-	-100.00%
31 Dec, 17	31	-	7,924,820	1.57%	1309.61%	0.09%	15	36.36%	3	-57.14%
30 Sep, 17	31	-	7,802,680	-1.39%	1188.72%	0.06%	11	-31.25%	7	-12.50%
30 Jun, 17	31	34.78%	7,912,372	53.08%	1401.50%	0.15%	16	33.33%	8	60.00%
31 Mar, 17	23	-8.00%	5,168,676	-7.75%	966.77%	0.05%	12	20.00%	5	25.00%
31 Dec, 16	25	-10.71%	5,602,738	-5.50%	1430.48%	0.12%	10	-23.08%	4	-42.86%
30 Sep, 16	28	16.67%	5,928,539	7.23%	1112.21%	0.08%	13	-45.83%	7	-
30 Jun, 16	24	-	5,528,832	-	1173.74%	-	24	-	-	-

Spyre Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 29, 2023	Fairmount Funds Management LLC	director, 10 percent owner		J-Other	Sell	3,435,480	-	-	-
Dec 08, 2023	Albers Jeffrey W.	director	-	C-Conversion	Sell	859	-	-	-
Nov 28, 2023	Fairmount Funds Management LLC	director, 10 percent owner		C-Conversion	Sell	85,887	-	-	-
Nov 27, 2023	Turtle Cameron	director, officer	Chief Executive Officer	C-Conversion	Sell	18,086	-	-	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 29, 2023	Fairmount Funds Management LLC	director, 10 percent owner		J-Other	Buy	406,038	-	-	406,038
Dec 29, 2023	Fairmount Funds Management LLC	director, 10 percent owner		J-Other	Sell	3,435,480	-	-	-
Dec 22, 2023	Burrows Scott L	officer	Chief Financial Officer	A-Award	Buy	134,953	-	-	134,953
Dec 11, 2023	Fairmount Funds Management LLC	director, 10 percent owner		A-Award	Buy	16,667	-	-	16,667
Dec 08, 2023	Albers Jeffrey W.	director	-	A-Award	Buy	50,000	$10.39	$519.50K	50,000
Dec 08, 2023	Albers Jeffrey W.	director	-	C-Conversion	Buy	34,360	-	-	34,360
Dec 08, 2023	Albers Jeffrey W.	director	-	C-Conversion	Sell	859	-	-	-
Dec 08, 2023	Albers Jeffrey W.	director	-		Buy	34,360	-	-	-
Nov 28, 2023	Fairmount Funds Management LLC	director, 10 percent owner		C-Conversion	Buy	3,435,480	-	-	3,435,480
Nov 28, 2023	Fairmount Funds Management LLC	director, 10 percent owner		C-Conversion	Sell	85,887	-	-	-
Nov 27, 2023	Albers Jeffrey W.	director	-	A-Award	Buy	50,000	$10.39	$519.50K	50,000
Nov 27, 2023	Stelzer Laurie	director	-	A-Award	Buy	50,000	$10.39	$519.50K	50,000
Nov 27, 2023	Albers Jeffrey W.		-		Buy	-	-	-	-
Nov 27, 2023	Stelzer Laurie		-		Buy	-	-	-	-
Nov 27, 2023	Turtle Cameron	director, officer	Chief Executive Officer	C-Conversion	Buy	723,440	-	-	746,507
Nov 27, 2023	Turtle Cameron	director, officer	Chief Executive Officer	A-Award	Buy	374,000	$10.39	$3.89M	374,000
Nov 27, 2023	Turtle Cameron	director, officer	Chief Executive Officer	C-Conversion	Sell	18,086	-	-	-
Sep 05, 2023	King-Jones Heidy	officer	See Remarks	A-Award	Buy	13,495,255	$0.58	$7.83M	13,495,255
Sep 05, 2023	King-Jones Heidy		-		Buy	-	-	-	-
Sep 05, 2023	Burrows Scott L	officer	Chief Financial Officer	A-Award	Buy	10,121,441	$0.58	$5.87M	10,121,441

The last insider sell of Spyre Therapeutics's stock was made by Fairmount Funds Management LLC on Dec 29 2023, selling 3,435,480 shares at - per share (valued at -).

Spyre Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	10	4	250.00%
Q3 2023	2	-	-
Q2 2023	5	4	125.00%
Q1 2023	4	-	-
Q4 2022	2	2	100.00%
Q3 2022	5	3	166.67%
Q2 2022	9	-	-
Q1 2022	8	-	-
Q4 2021	7	-	-
Q3 2021	4	-	-
Q2 2021	8	-	-
Q1 2021	5	9	55.56%
Q4 2020	1	-	-
Q2 2020	7	-	-
Q1 2020	5	-	-
Q4 2019	4	2	200.00%
Q2 2019	15	-	-
Q1 2019	8	5	160.00%
Q4 2018	3	3	100.00%
Q3 2018	11	8	137.50%

10 total buy trades, and 4 total sell trades (buy/sell ratio of 2.50%) were made by Spyre Therapeutics's insiders, as of Q4 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	-	-	-
Q3 2023	-	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	1	-	-
Q2 2022	1	-	-
Q1 2022	3	-	-
Q4 2021	6	-	-
Q3 2021	3	-	-
Q2 2021	-	-	-
Q1 2021	-	-	-
Q4 2020	-	-	-
Q2 2020	1	-	-
Q1 2020	-	-	-
Q4 2019	-	-	-
Q2 2019	9	-	-
Q1 2019	1	-	-
Q4 2018	-	-	-
Q3 2018	1	2	50.00%

As of Q4 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Spyre Therapeutics's stocks.

Spyre Therapeutics Peer Ownership

Ticker	Company
SNTI	Senti Biosciences, Inc.
BLCM	Bellicum Pharmaceuticals, Inc.
NUVB	Nuvation Bio Inc.
IKNA	Ikena Oncology, Inc.
EWTX	Edgewise Therapeutics, Inc.
BPTH	Bio-Path Holdings, Inc.
CTMX	CytomX Therapeutics, Inc.
LABP	Landos Biopharma, Inc.
HILS	Tharimmune, Inc.
CING	Cingulate Inc.
ASMB	Assembly Biosciences, Inc.
EFTR	eFFECTOR Therapeutics, Inc.
DSGN	Design Therapeutics, Inc.
XLO	Xilio Therapeutics, Inc.
NLTX	Neurogene Inc.
CBIO	Gyre Therapeutics, Inc.
BNTC	Benitec Biopharma Inc.
TIL	Instil Bio, Inc.
ALRN	Aileron Therapeutics, Inc.
ELYM	Eliem Therapeutics, Inc.

AGLE Ownership FAQ

Who Owns Spyre Therapeutics?

Spyre Therapeutics is owned by institutional shareholders (17.16%), insiders (2.40%), and public (80.43%). The largest institutional shareholder of Spyre Therapeutics is YU FAN (0% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.06% of total shares).

Who are the major institutional shareholders of Spyre Therapeutics?

Spyre Therapeutics's major institutional shareholders are YU FAN. The top five shareholders own together 0% of the company's share outstanding.

How many Spyre Therapeutics shareholders are there?

As of Mar 2024, there are 1 institutional shareholders of Spyre Therapeutics.

What percentage of Spyre Therapeutics is owned by YU FAN?

YU FAN owns 0 shares of Spyre Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).